Skip to main content

Table 2 Assessment schedule (time in weeks)

From: The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample

  B Stabilization O Maintenance
  -1 0 4 8 12 14 16 Q 2 wks × 8 wks then monthly visits Cross over to Valproic Acid for mood episode on lithium
CGI-S-BP by doctor X X X X X X X X X
Mood episode checklist X X X X X X X X X
Consent X         
MINI- PLUS X         
Demographics/course of illness X         
HAM-A   X    X   X   X
MADRS   X X   X   X X X
YMRS/CARS – M   X X   X    X X
Side Effects Survey X X X X X X X X X
Q-LES-Q X     X   X   X
IRS X     X   X   X
MSSI X X X   X   X   X
Serious Adverse Event Form X X X X X   X X X
  1. O observation phase, B baseline, ET Early Termination, Mini-PLUS Extended Mini-International Neuropsychiatric Interview, MADRS Montgomery Asberg Depression Rating Scale, QIDS-SR 16 Quick Inventory of Depressive Symptomatology Self-Report, YMRS Young Mania Rating Scale, CARS-M: Clinician Administered Rating Scale for Mania, HAM-A Hamilton Anxiety Rating Scale, CGI-BP Clinical Global Impressions of Severity - Bipolar Version, Q-LES-Q quality of life, enjoyment, and satisfaction questionnaire, IRS impulsivity rating scale, MSSI The Modified Scale of Suicidal Ideation